Medibio Acquires Vital Conversations Pty

Medibio is a medical technology company that has developed an objective test to assist in the diagnosis of depression, chronic stress and other mental health disorders. Based on research conducted over 15 years at the University of Western Australia, this test utilizes patented (pending) circadian heart rate variability and cloud based proprietary algorithms to deliver a quantifiable measure to assist in a clinical diagnosis. Clinical studies are being undertaken by Johns Hopkins University School of Medicine and Ottawa University, among others, to validate the test. Medibio was founded in 1987 and is based in Melbourne, Australia.